advertisement
Myers JS 20
Showing records 1 to 20 | Display all abstracts from Myers JS86586 Fixed-combination topical anti-hypertensive ophthalmic agents
Machen L
Expert Opinion in Pharmacotherapy 2020; 21: 1269-1282
86755 iStent inject trabecular micro-bypass stents with topical prostaglandin as standalone treatment for open-angle glaucoma: 4-year outcomes
Berdahl J
Clinical and Experimental Ophthalmology 2020; 48: 767-774
86185 Pathophysiology and management of glaucoma and ocular hypertension related to trauma
Razeghinejad R
Survey of Ophthalmology 2020; 65: 530-547
86766 Monitoring Glaucomatous Functional Loss Using an Artificial Intelligence-Enabled Dashboard
Yousefi S
Ophthalmology 2020; 127: 1170-1178
86586 Fixed-combination topical anti-hypertensive ophthalmic agents
Machen L
Expert Opinion in Pharmacotherapy 2020; 21: 1269-1282
86766 Monitoring Glaucomatous Functional Loss Using an Artificial Intelligence-Enabled Dashboard
Elze T
Ophthalmology 2020; 127: 1170-1178
86586 Fixed-combination topical anti-hypertensive ophthalmic agents
Razeghinejad R
Expert Opinion in Pharmacotherapy 2020; 21: 1269-1282
86755 iStent inject trabecular micro-bypass stents with topical prostaglandin as standalone treatment for open-angle glaucoma: 4-year outcomes
Voskanyan L
Clinical and Experimental Ophthalmology 2020; 48: 767-774
86185 Pathophysiology and management of glaucoma and ocular hypertension related to trauma
Lin MM
Survey of Ophthalmology 2020; 65: 530-547
86755 iStent inject trabecular micro-bypass stents with topical prostaglandin as standalone treatment for open-angle glaucoma: 4-year outcomes
Myers JS
Clinical and Experimental Ophthalmology 2020; 48: 767-774
86185 Pathophysiology and management of glaucoma and ocular hypertension related to trauma
Lee D
Survey of Ophthalmology 2020; 65: 530-547
86586 Fixed-combination topical anti-hypertensive ophthalmic agents
Myers JS
Expert Opinion in Pharmacotherapy 2020; 21: 1269-1282
86766 Monitoring Glaucomatous Functional Loss Using an Artificial Intelligence-Enabled Dashboard
Pasquale LR
Ophthalmology 2020; 127: 1170-1178
86185 Pathophysiology and management of glaucoma and ocular hypertension related to trauma
Katz LJ
Survey of Ophthalmology 2020; 65: 530-547
86766 Monitoring Glaucomatous Functional Loss Using an Artificial Intelligence-Enabled Dashboard
Saeedi O
Ophthalmology 2020; 127: 1170-1178
86755 iStent inject trabecular micro-bypass stents with topical prostaglandin as standalone treatment for open-angle glaucoma: 4-year outcomes
Katz LJ
Clinical and Experimental Ophthalmology 2020; 48: 767-774
86766 Monitoring Glaucomatous Functional Loss Using an Artificial Intelligence-Enabled Dashboard
Wang M
Ophthalmology 2020; 127: 1170-1178
86755 iStent inject trabecular micro-bypass stents with topical prostaglandin as standalone treatment for open-angle glaucoma: 4-year outcomes
Samuelson TW
Clinical and Experimental Ophthalmology 2020; 48: 767-774
86185 Pathophysiology and management of glaucoma and ocular hypertension related to trauma
Myers JS
Survey of Ophthalmology 2020; 65: 530-547
86766 Monitoring Glaucomatous Functional Loss Using an Artificial Intelligence-Enabled Dashboard
Shen LQ; Wellik SR; De Moraes CG; Myers JS; Boland MV
Ophthalmology 2020; 127: 1170-1178
